Multiple cycles of PBPC-supported high-dose carboplatin and paclitaxel following mobilization with epirubicin and cisplatin are feasible but ineffective in treating patients with advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

Multiple cycles of PBPC-supported high-dose carboplatin and paclitaxel following mobilization with epirubicin and cisplatin are feasible but ineffective in treating patients with advanced non-small cell lung cancer

Published:2007-08-13 Issue:8 Volume:40 Page:735-739
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

De Giorgi U,Rosti G,Ciucci G,Kopf B,Minzi C,Argnani M,Marangolo M

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1705793.pdf

Reference28 articles.

1. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995; 311: 899–909.

2. Bojko P, Welt A, Schleucher R, Borquez D, Scheulen ME, Vanhoefer U et al. High-dose chemotherapy with autologous stem cell transplantation in patients with oligometastatic breast cancer. Bone Marrow Transplant 2004; 34: 637–643.

3. Quantin X, Riviere A, Daures JP, Oliver P, Comte-Bardonnet M, Khial F et al. Phase I-II study of high dose epirubicin plus cisplatin in unresectable non-small-cell lung cancer: searching for the maximal tolerated dose. Am J Clin Oncol 2000; 23: 192–196.

4. Bedano PM, Brames MJ, Williams SD, Juliar BE, Einhorn LH . Phase II study of cisplatin plus epirubicin salvage chemotherapy in refractory germ cell tumors. J Clin Oncol 2006; 24: 5403–5407.

5. Pedrazzoli P, Perotti C, Da Prada GA, Bertolini F, Gibelli N, Torretta L et al. Collection of circulating progenitor cells after epirubicin, paclitaxel and filgrastim in patients with metastatic breast cancer. Br J Cancer 1997; 75: 1368–1372.